Topic: Joshua Schimmer
Shares of his company MannKind (MNKD) are rising Friday morning on hope that Mann is back on track to get inhaled insulin product Afrezza approved...
Orexigen Therapeutics (OREX) will know by the end of the month whether its diet pill will be approved, rejected or delayed.. In the meantime, diet...
Shares of Incyte (INCY) are trading up today after the company announced positive results for a late-stage human study testing its bone marrow...
The rare bone marrow cancer myelofibrosis is hardly a household name. But some companies may see their shares move based on drug study results to...
MannKind Corporation (MNKD) Q3 2009 Earnings Call November 02, 2009 5:00 pm ET. (Operator Instructions) Joining us today from MannKind are Chairman and CEO, Alfred Mann; President and COO, Hakan Edstrom; Chief Financial Officer, Matthew Pfeffer and Chief Scientific Officer, Dr ...
